SMTL ID : 6fmi.2 (1 other biounit)

pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamothioyl) pyrrolidin-1-yl)-1-oxopropan-2-yl)acetamide (ligand 2)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x DV2: ~{N}-[(2~{S})-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamothioyl]-4-oxidanyl-pyrrolidin-1-yl]-1-oxidanylidene-propan-2-yl]ethanamide(Non-covalent)

DV2.1: 11 residues within 4Å: Chain C: W.37, F.40, Y.47, P.48, R.56, I.58, H.59, S.60, Y.61, H.64, W.66 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:W.37, C:I.58, C:I.58, C:W.66 Hydrogen bonds: C:W.37, C:R.56, C:H.59, C:Y.61, C:H.64 pi-Stacking: C:Y.47

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Soares, P. et al., Thioamide substitution to probe the hydroxyproline recognition of VHL ligands. Bioorg. Med. Chem. (2018)

Release Date

2018-04-11

Peptides

Elongin-B: A
Elongin-C: B
von Hippel-Lindau disease tumor suppressor: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

C
F

Elongin-B

Elongin-C

von Hippel-Lindau disease tumor suppressor

Related Entries With Identical Sequence